How did Axogen's revenue and expenses shift in Q4 2024?

Axogen's revenue and expenses in Q4 2024 are not available. However, we can infer some potential shifts based on the available data from Q2 and Q3 2024.

1. Revenue Shift:
   • In Q2 2024, Axogen reported a 25.6% increase in revenue, reaching $47.9 million. Assuming a similar growth trajectory in Q4, one might expect an increase from the previous year's Q4 revenue.
   • The company raised its full-year revenue guidance to $182 million to $186 million for 2024, indicating confidence in continued growth. This suggests that the Q4 revenue would need to be significant to meet or exceed the new guidance.
2. Expense Shift:
   • Axogen's operating expenses decreased by 2.2% to $35.8 million in Q2 2024, down from $36.6 million in the same period of the previous year. This trend of reduced expenses could potentially continue in Q4, assuming no significant changes in business operations.
   • Gross margin decreased to 73.8% in Q2 2024 compared to 77.7% in the same period of the previous year, due to higher relative costs from a new facility. The impact of this facility on Q4 gross margin would be an important factor to consider.

In conclusion, Axogen's revenue in Q4 2024 likely showed continued growth, while expenses might have been slightly lower than the previous year, depending on operational efficiencies and the impact of the new facility on costs.